Trial intelligence / Profile preview

Metabolic differences in narcolepsy and effect of sodium oxybate

NL-OMON31397Not yet recruiting

Sponsor
Leiden University Medical Center
Start
Jan 2008
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of sodium oxybate in narcolepsy (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: Difference in energy expenditure between narcolepsy patients and healthy controls, Difference in insulin sensitivity between narcolepsy patients and healthy controls and 1 more. Planned start Jan 2008; status: not yet recruiting.

02

Drugs

sodium oxybate
03

Conditions

narcolepsy

Beyond the preview

Go deeper on NL-OMON31397.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON31397.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call